SLC
CL icon

Second Line Capital’s Colgate-Palmolive CL Stock Holding History

Second Line Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Sell
4,774
-11
-0.2% -$962 0.08% 91
2026
Q1 		$408K Buy
4,785
+15
+0.3% +$1.34K 0.08% 101
2025
Q4 		$377K Hold
4,770
– – 0.08% 90
2025
Q3 		$381K Hold
4,770
– – 0.08% 90
2025
Q2 		$434K Hold
4,770
– – 0.1% 81
2025
Q1 		$447K Buy
4,770
+1,418
+42% +$127K 0.12% 74
2024
Q4 		$305K Hold
3,352
– – 0.08% 90
2024
Q3 		$348K Hold
3,352
– – 0.09% 84
2024
Q2 		$325K Buy
3,352
+900
+37% +$83K 0.1% 80
2024
Q1 		$221K Buy
+2,452
New +$208K 0.07% 102

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Second Line Capital's CL Position: Q2 2026 in Review

Second Line Capital reduced its Colgate-Palmolive (CL) stake by 0.23% in Q2 2026, selling an estimated $962 and leaving 4,774 shares worth $438K. The position accounts for 0.08% of the portfolio, ranked #91.

Second Line Capital first reported a position in CL in Q1 2024 and has held it in 10 quarters since. The position peaked at $447K in Q1 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Second Line Capital held 4,774 shares of Colgate-Palmolive worth $438K as of Q2 2026.
  • Second Line Capital sold 11 Colgate-Palmolive shares in Q2 2026, an estimated $962.
  • Colgate-Palmolive made up 0.08% of Second Line Capital's portfolio in Q2 2026, its #91 holding.
  • Second Line Capital first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • Second Line Capital's Colgate-Palmolive position peaked at $447K in Q1 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Second Line Capital's 13F filing for Q2 2026, filed 12 Aug 2026.